Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis: A Sham Control Study Publisher Pubmed



Fatemi Naeini F1 ; Abtahinaeini B1 ; Pourazizi M2 ; Nilforoushzadeh MA3 ; Mirmohammadkhani M4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Stud. Research Committee, Semnan University of Medical Sciences, Semnan, Iran
  3. 3. Research Centre for Social Determinants of Health, Department of Community Medicine, Semnan University of Medical Sciences, Semnan, Iran
  4. 4. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Australasian Journal of Dermatology Published:2015


Abstract

Background/ Objective Primary axillary hyperhidrosis (PAH) creates social stress in patients. Although there are several options for treating PAH, only surgical modalities have conferred a permanent solution. This study evaluated the clinical effectiveness of fractionated microneedle radiofrequency (FMR) treatment for PAH. Methods This study is based on a single-blind, sham control comparative design. In all, 25 patients with severe PAH underwent three sessions of FMR at 3-week intervals. One side was treated with FMR while the other was sham controlled. Efficacy was evaluated using the hyperhidrosis disease severity scale (HDSS), sweating intensity visual analogue scale (VAS) and patient satisfaction at baseline, 3 weeks after each session and at 3 months after the last. Skin biopsies were obtained from two enrolled patients. Results The HDSS and VAS demonstrated significant improvement after treatment on the treated side in comparison with the control side. The mean ± SD of the HDSS after 21 weeks were 1.87 ± 0.61 and 3.38 ± 0.49 (P < 0.001) for the treated and the controlled side, respectively. The follow-up evaluation revealed that 79% of the patients showed a 1 or 2-score decrease in HDSS. In total, 80% of patients reported more than 50% satisfaction at the end of the study. Histopathological findings showed a decrease of the number of the sweat glands in the treated side, confirming the above findings. Conclusions Treatment of PAH with FMR as a non-invasive modality can be a safe option with positive therapeutic effects on HDSS without any long-lasting side effects. © 2014 The Australasian College of Dermatologists.